Sanofi ousts CEO Hudson after stalled turnaround at vaccine giant [CNBC]
Sanofi - American Depositary Shares (SNY)
US:NYSE Investor Relations:
sanofi.com/en/investors
Company Research
Source: CNBC
Adam Galici | CNBC French drugmaker Sanofi ousted CEO Paul Hudson on Thursday, ending a six-year tenure marked by a stalled drive to replace blockbuster drugs going off ?patent and rising pressure from U.S. anti-vaccine policy ?and rhetoric. The company said it had ?appointed Belén Garijo, the head of German drugmaker Merck KGaA , as new chief executive, adding that the 65-year-old Spanish executive would take over in late April. Sanofi shares fell nearly 6% on Thursday, with some analysts pointing to Garijo's relatively low profile. “It is fair to say that Belen would not have been on many shortlists as potential successor ?given ?at Merck KGaA she arguably never reached the profile of prior executives there”, brokerage Jefferies ?analysts said in a note. Hudson, 58, who was pushed out only two months before his tenure was up for renewal, did not respond to a Reuters request for comment. He had admitted on a call with analysts late last month that his plans had not moved as
Show less
Read more
Impact Snapshot
Event Time:
SNY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SNY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SNY alerts
High impacting Sanofi - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
SNY
News
- Does Sanofi's CEO Overhaul And Governance Shift Change The Bull Case For Sanofi (ENXTPA:SAN)? [Yahoo! Finance]Yahoo! Finance
- Sanofi (NASDAQ:SNY) was downgraded by analysts at Bank of America Corporation from a "buy" rating to a "neutral" rating.MarketBeat
- Sanofi replaces chief Paul Hudson with Merck executive after R&D woes [Yahoo! Finance]Yahoo! Finance
- Sanofi names Belén Garijo as CEO [Seeking Alpha]Seeking Alpha
- Press Release: Belén Garijo to become Chief Executive Officer of Sanofi [Yahoo! Finance]Yahoo! Finance
SNY
Sec Filings
- 2/12/26 - Form 6-K
- 2/11/26 - Form 13F-HR
- 2/10/26 - Form 6-K
- SNY's page on the SEC website